-
Signature
-
/s/ Kyle Piskel
-
Issuer symbol
-
ADPT
-
Transactions as of
-
12 Jan 2026
-
Net transactions value
-
-$25,139
-
Form type
-
4
-
Filing time
-
14 Jan 2026, 19:17:23 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| PISKEL KYLE |
Chief Financial Officer |
C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION, 1165 EASTLAKE AVE E, SEATTLE |
/s/ Kyle Piskel |
14 Jan 2026 |
0001780662 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ADPT |
Common Stock |
Options Exercise |
$52,081 |
+4,290 |
+2% |
$12.14 |
220,927 |
12 Jan 2026 |
Direct |
F1 |
| transaction |
ADPT |
Common Stock |
Sale |
$77,220 |
-4,290 |
-1.9% |
$18.00 |
216,637 |
12 Jan 2026 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ADPT |
Stock Option (right to buy) |
Options Exercise |
$0 |
-4,290 |
-50% |
$0.000000 |
4,291 |
12 Jan 2026 |
Common Stock |
4,290 |
$12.14 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: